Compugen (CGEN) Cash & Current Investments (2009 - 2026)
Compugen recorded quarterly Cash & Current Investments of $91.8 million in Q1 2026, down 32.71% quarter-over-quarter from $136.4 million in Q4 2025.
Compugen's Cash & Current Investments history runs 12 years deep, the most recent figure standing at $91.8 million for Q1 2026.
- In Q1 2026, Cash & Current Investments changed N/A year-over-year to $91.8 million; the TTM figure through Mar 2026 stood at $91.8 million (changed N/A YoY), while the FY2025 annual figure was $136.4 million, up 71.25% from the prior year.
- Cash & Current Investments came in at $91.8 million for Q1 2026 at Compugen, down from $136.4 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $136.4 million in Q4 2025 to a low of $11.1 million in Q4 2022.
- A 5-year average of $68.9 million and a median of $79.6 million in 2024 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments plunged 90.55% in 2022 and jumped 210.65% in 2024, its largest moves.
- Compugen's Cash & Current Investments stood at $11.1 million in 2022, then soared by 131.78% to $25.6 million in 2023, then surged by 210.65% to $79.6 million in 2024, then surged by 71.25% to $136.4 million in 2025, then slumped by 32.71% to $91.8 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $91.8 million, $136.4 million, and $79.6 million for Q1 2026, Q4 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.13 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.01 Bn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | 91.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91.75 Mn |
| Dec 31, 2025 | 99.88 Mn |
| Sep 30, 2025 | 7.46 Mn |
| Jun 30, 2025 | 6.47 Mn |
| Mar 31, 2025 | 14.58 Mn |
| Dec 31, 2024 | 79.63 Mn |
| Sep 30, 2024 | 7.22 Mn |
| Jun 30, 2024 | 11.88 Mn |
| Dec 31, 2023 | 14.26 Mn |
| Jun 30, 2023 | 17.69 Mn |
| Dec 31, 2022 | 11.06 Mn |
| Jun 30, 2022 | 8.73 Mn |
| Dec 31, 2021 | 117.05 Mn |
| Jun 30, 2021 | 8.53 Mn |
| Dec 31, 2020 | 123.77 Mn |
| Jun 30, 2020 | 13.11 Mn |
| Dec 31, 2019 | 9.84 Mn |
| Jun 30, 2019 | 6.86 Mn |
| Dec 31, 2018 | 7.07 Mn |
| Jun 30, 2018 | 11.57 Mn |
| Dec 31, 2017 | 26.52 Mn |
| Jun 30, 2017 | 17.96 Mn |
| Dec 31, 2016 | 10.70 Mn |
| Jun 30, 2016 | 11.77 Mn |
| Dec 31, 2015 | 11.85 Mn |
| Jun 30, 2015 | 26.19 Mn |
| Mar 31, 2015 | 543,000.00 |
| Dec 31, 2014 | 26.19 Mn |
| Jun 30, 2014 | 28.91 Mn |
| Dec 31, 2013 | 28.91 Mn |
| Sep 30, 2013 | 101,000.00 |
| Jun 30, 2013 | 13.19 Mn |
| Mar 31, 2013 | 98,000.00 |
| Dec 31, 2012 | 19.59 Mn |
| Sep 30, 2012 | 91,000.00 |
| Jun 30, 2012 | 8.88 Mn |
| Mar 31, 2012 | 95,000.00 |
| Dec 31, 2011 | 22.37 Mn |
| Sep 30, 2011 | 94,000.00 |
| Jun 30, 2011 | 7.40 Mn |
| Mar 31, 2011 | 99,000.00 |
| Dec 31, 2010 | 21.82 Mn |
| Sep 30, 2010 | 4.43 Mn |
| Jun 30, 2010 | 15.28 Mn |
| Mar 31, 2010 | 152,000.00 |
| Dec 31, 2009 | 15.30 Mn |
| Sep 30, 2009 | 4.65 Mn |
| Jun 30, 2009 | 4.65 Mn |